2212-1374

Journal of Bone Oncology

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 816 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact816 DOIs
2

Attach ORCID iDs across 628 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact628 DOIs
3

Deposit reference lists for 131 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact131 DOIs

DOIs for this ISSN

Showing the top 5 of 816 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Management of Aromatase Inhibitor-Associated Bone Loss (AIBL… (10.1016/j.jbo.2017.03.001)
Abstract ORCID
118.83 237
2 Benign tumours of the bone: A review (10.1016/j.jbo.2015.02.001)
Abstract ORCID
116.52 213
3 Metastatic bone disease: Pathogenesis and therapeutic option… (10.1016/j.jbo.2018.10.004)
Abstract ORCID
113.48 185
4 Epidemiology of spinal metastases, metastatic epidural spina… (10.1016/j.jbo.2022.100446)
Abstract ORCID
112.28 175
5 Receptor tyrosine kinases: Characterisation, mechanism of ac… (10.1016/j.jbo.2015.01.001)
Abstract ORCID
106.84 136
6 The role of tumour-associated macrophages in bone metastasis (10.1016/j.jbo.2016.03.004)
Abstract ORCID
104.50 122
7 The role of CXCR4 in multiple myeloma: Cells’ journey from b… (10.1016/j.jbo.2019.100253)
Abstract ORCID
103.41 116
8 Risk and clinicopathological features of osteosarcoma metast… (10.1016/j.jbo.2019.100230)
Abstract ORCID
102.27 110
9 The role of osteoblasts in bone metastasis (10.1016/j.jbo.2016.03.007)
Abstract ORCID
100.64 102
10 Myeloma bone disease: Pathophysiology and management (10.1016/j.jbo.2013.04.001)
Abstract ORCID
99.78 98
11 Bone metastases in thyroid cancer (10.1016/j.jbo.2020.100282)
Abstract ORCID
98.19 91
12 Incidence, consequences and treatment of bone metastases in… (10.1016/j.jbo.2013.09.001)
Abstract ORCID
97.47 88
13 Prognostic factors in osteosarcoma: A study level meta-analy… (10.1016/j.jbo.2020.100281)
Abstract ORCID
96.72 85
14 Incidence and consequences of bone metastases in lung cancer… (10.1016/j.jbo.2012.12.004)
Abstract ORCID
96.47 84
15 The role of biomarkers in the management of bone-homing mali… (10.1016/j.jbo.2017.09.001)
Abstract ORCID
95.95 82
16 Overexpression of lncRNA UCA1 promotes osteosarcoma progress… (10.1016/j.jbo.2016.05.003)
Abstract ORCID
94.88 78
17 Advances in limb salvage treatment of osteosarcoma (10.1016/j.jbo.2017.11.005)
Abstract ORCID
94.88 78
18 The anti-tumour effects of zoledronic acid (10.1016/j.jbo.2013.12.001)
Abstract ORCID
94.32 76
19 The role of osteoclasts in breast cancer bone metastasis (10.1016/j.jbo.2016.02.008)
Abstract ORCID
94.32 76
20 The role of 18F–NaF PET/CT in metastatic bone disease (10.1016/j.jbo.2015.08.002)
Abstract ORCID
92.56 70
21 New perspective into mesenchymal stem cells: Molecular mecha… (10.1016/j.jbo.2021.100372)
Abstract ORCID
91.94 68
22 The role of the bone microenvironment in skeletal metastasis (10.1016/j.jbo.2012.11.002)
Abstract ORCID
91.63 67
23 miRNA-223 is a potential diagnostic and prognostic marker fo… (10.1016/j.jbo.2016.05.001)
Abstract ORCID
91.63 67
24 Hypoxia-induced autophagy as an additional mechanism in huma… (10.1016/j.jbo.2016.03.001)
Abstract ORCID
91.30 66
25 Blockade of CCL2 enhances immunotherapeutic effect of anti-P… (10.1016/j.jbo.2018.01.002)
Abstract ORCID
91.30 66
26 The bone metastasis niche in breast cancer: potential overla… (10.1016/j.jbo.2019.100244)
Abstract ORCID
90.31 63
27 Aneurysmal bone cyst: A review of 65 patients (10.1016/j.jbo.2019.100255)
Abstract ORCID
89.27 60
28 Baicalin induces apoptosis and autophagy in human osteosarco… (10.1016/j.jbo.2022.100415)
Abstract ORCID
89.27 60
29 Experience with denosumab (XGEVA®) for prevention of skeleta… (10.1016/j.jbo.2022.100416)
Abstract ORCID
88.91 59
30 A comparative study between limb-salvage and amputation for… (10.1016/j.jbo.2016.01.001)
Abstract ORCID
88.54 58
31 Current strategies for the treatment of solitary and aneurys… (10.1016/j.jbo.2021.100384)
Abstract ORCID
88.17 57
32 Role of autophagy in osteosarcoma (10.1016/j.jbo.2019.100235)
Abstract ORCID
87.41 55
33 Application of 3D-printed PEEK scapula prosthesis in the tre… (10.1016/j.jbo.2018.07.012)
Abstract ORCID
87.02 54
34 Radiomics signature extracted from diffusion-weighted magnet… (10.1016/j.jbo.2019.100263)
Abstract ORCID
86.21 52
35 Quality of life after palliative radiotherapy in bone metast… (10.1016/j.jbo.2014.11.001)
Abstract ORCID
84.95 49
36 Surface osteosarcoma: Clinical features and therapeutic impl… (10.1016/j.jbo.2015.07.002)
Abstract ORCID
84.51 48
37 Inhibition of IL-18-mediated myeloid derived suppressor cell… (10.1016/j.jbo.2017.10.002)
Abstract ORCID
84.51 48
38 A definition of “uncomplicated bone metastases” based on pre… (10.1016/j.jbo.2014.12.001)
Abstract ORCID
83.60 46
39 RANK and RANK ligand expression in primary human osteosarcom… (10.1016/j.jbo.2015.06.002)
Abstract ORCID
83.14 45
40 Systematic review: Incidence, risk factors, survival and tre… (10.1016/j.jbo.2018.09.009)
Abstract ORCID
83.14 45
41 Incidence of pain flare in radiation treatment of bone metas… (10.1016/j.jbo.2014.10.001)
Abstract ORCID
82.17 43
42 Targeting ferroptosis in osteosarcoma (10.1016/j.jbo.2021.100380)
Abstract ORCID
82.17 43
43 Immune checkpoint inhibitors in bone metastasis: Clinical ch… (10.1016/j.jbo.2023.100505)
Abstract ORCID
82.17 43
44 Health resource utilization associated with skeletal-related… (10.1016/j.jbo.2014.04.001)
Abstract ORCID
81.67 42
45 Exosomes derived from bone marrow mesenchymal stem cells pro… (10.1016/j.jbo.2020.100280)
Abstract ORCID
81.67 42
46 Clinical characteristics and risk factors analysis of lung m… (10.1016/j.jbo.2017.04.001)
Abstract ORCID
81.16 41
47 Chondroblastoma in pelvis and extremities- a signle centre s… (10.1016/j.jbo.2019.100248)
Abstract ORCID
81.16 41
48 Osteochondroma: Review of 431 patients from one medical inst… (10.1016/j.jbo.2017.08.002)
Abstract ORCID
80.64 40
49 Prognostic nomograms for predicting overall and cancer-speci… (10.1016/j.jbo.2018.09.012)
Abstract ORCID
80.64 40
50 Long noncoding RNA UCA1 promotes osteosarcoma metastasis thr… (10.1016/j.jbo.2019.100228)
Abstract ORCID
80.64 40